Osfirm
Osfirm Co., Ltd. is a South Korea–based medical device and biomaterials company founded in 2018. The company develops synthetic bone graft materials and implantable regenerative medical devices, conducts R&D in biomimetic inorganic materials (including whitlockite-based formulations), and collaborates with hospitals and universities for translational projects. It holds device-related certifications and multiple patents on biomaterial synthesis methods.
Industries
Nr. of Employees
small (1-50)
Osfirm
Products
Nano-scale biocompatible raw material for medical devices
Nano-sized biocompatible inorganic material intended as a base material for medical devices and drug–device products.
Implantable bone graft materials
Resorbable bone graft products designed to support new bone formation and reconstruction of bone defects.
Biodegradable plates and screws for bone fixation
Bioresorbable fixation hardware intended to stabilize fractures while supporting bone regeneration and then degrade.
3D-printed patient-specific implants
Additively manufactured implants using biocompatible feedstock for cranial and other reconstructive indications.
Oral composition for dental sensitivity and wear
An oral care formulation intended to reduce excessive tooth wear and treat dental sensitivity.
골접합용 판·나사
골절된 뼈를 고정하거나 지지할 때 사용되어 신생골의 형성을 촉진하며 생분해되는 판·나사
Nano-scale biocompatible raw material for medical devices
Nano-sized biocompatible inorganic material intended as a base material for medical devices and drug–device products.
Implantable bone graft materials
Resorbable bone graft products designed to support new bone formation and reconstruction of bone defects.
Biodegradable plates and screws for bone fixation
Bioresorbable fixation hardware intended to stabilize fractures while supporting bone regeneration and then degrade.
3D-printed patient-specific implants
Additively manufactured implants using biocompatible feedstock for cranial and other reconstructive indications.
Oral composition for dental sensitivity and wear
An oral care formulation intended to reduce excessive tooth wear and treat dental sensitivity.
골접합용 판·나사
골절된 뼈를 고정하거나 지지할 때 사용되어 신생골의 형성을 촉진하며 생분해되는 판·나사
Expertise Areas
- Biomaterials development for bone regeneration
- Implantable medical device development
- 3D printing for patient-specific implants
- Regulatory compliance and ISO 13485 quality systems
Key Technologies
- Whitlockite biomaterial formulations
- Calcium phosphate particle-size control methods
- Spatial and temporal separation synthesis techniques
- Biomimetic inorganic nanoparticles
News & Updates
Exhibition participation listing (gallery item).
Media coverage highlighting application of whitlockite in bone grafts and claims about addressing limitations of existing products.
Industry press coverage announcing launch of an implantable whitlockite biomaterial with reported biodegradability and regenerative properties.
Multiple articles reporting MOUs and collaborative research agreements with universities and hospitals for R&D and translational work.
Company holds ISO 13485 certification for medical device quality management systems (BSI certificate dated 2020-11-25).
Award/galleries include a 2025 ministerial commendation for contributions to advanced regenerative medicine (gallery listing).
Exhibition participation listing (gallery item).
Media coverage highlighting application of whitlockite in bone grafts and claims about addressing limitations of existing products.
Industry press coverage announcing launch of an implantable whitlockite biomaterial with reported biodegradability and regenerative properties.
Multiple articles reporting MOUs and collaborative research agreements with universities and hospitals for R&D and translational work.
Company holds ISO 13485 certification for medical device quality management systems (BSI certificate dated 2020-11-25).
Award/galleries include a 2025 ministerial commendation for contributions to advanced regenerative medicine (gallery listing).